Atlas Trials

Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial

Clinical trial NCT04361643 · UNKNOWN

Trial details

NCT number
NCT04361643
Sponsor
Hospital Universitario Getafe
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2020-10-27
Primary completion
2021-08-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.